ChartRow logo
Share this page
DDS
$654.11+1.20%
as of close, Oct 2, 2026
☾ AH $654.11 +1.20%
Dillard's Inc.Stock · Consumer DiscretionaryRussell 1000 0.002%US Stock Market 0.002%Russell 3000 0.002%
PeersTSLAAMZNNKEHDMCDBKNG

DDS financial statements

The full income statement, balance sheet, and cash-flow statement for Dillard's Inc. (DDS), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-08 16.2M2024-11 15.9M2025-02 15.9M2025-05 15.6M2025-08 15.6M2025-11 15.6M2026-01 15.6M2026-05 15.6M2026-08 15.6M-3.5% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofJan 31 ’26as ofFeb 1 ’25as ofFeb 3 ’24as ofJan 28 ’23as ofJan 29 ’22
Revenue6.47B-0.1%6.48B-4.0%6.75B-1.7%6.87B+3.7%6.62B+49.4%
2.56B-0.2%2.56B-5.8%2.72B-5.8%2.89B+5.2%2.75B+122.9%
Cost of revenue3.92B-0.1%3.92B-2.8%4.03B+1.2%3.98B+6.3%3.75B+22.1%
Selling, general & administrative1.76B+1.6%1.73B+0.8%1.72B+2.6%1.67B+9.0%1.54B+26.8%
Interest expense41.0M+2.8%39.9M+966.8%-4.60M-115.1%30.5M-29.2%43.1M-12.3%
Interest & investment income47.2M-11.9%53.6M+18.4%45.2M+252.7%12.8M+594.5%1.85M+265.7%
Net interest income——4.60M+115.1%-30.5M+29.2%-43.1M+12.3%
Equity-method income
407K————
Pre-tax income694M-4.8%730M-20.4%917M-17.4%1.11B+1.9%1.09B+809.5%
Income tax125M-8.5%136M-23.4%178M-18.4%218M-3.6%226M+376.3%
Net income570M-3.9%593M-19.7%739M-17.1%892M+3.4%862M+1303.7%
$36.42-1.1%$36.82-17.7%$44.73-12.0%$50.81+21.3%$41.88+1425.3%
EPS (basic)$36.42-1.1%$36.82-17.7%$44.73-12.0%$50.81+21.3%$41.88+1425.3%
Weighted-avg shares (basic)
————20.6M-9.3%
Weighted-avg shares (diluted)
————20.6M-9.3%
Dividends per share$31.10+19.6%$26.00+24.4%$20.90+32.3%$15.80+0.6%$15.70+2516.7%
Balance Sheetas ofJan 31 ’26as ofFeb 1 ’25as ofFeb 3 ’24as ofJan 28 ’23as ofJan 29 ’22
2.39B+0.8%2.37B+7.2%2.21B+6.6%2.07B+8.2%1.91B+15.2%
Cash & equivalents861M+20.0%718M-11.2%808M+24.3%650M-9.3%717M+98.9%
Accounts receivable39.7M-28.7%55.7M-8.0%60.5M+6.3%57.0M+43.2%39.8M+8.4%
Other current assets72.8M-24.8%96.8M-0.6%97.3M+13.9%85.5M+9.6%77.9M+32.8%
3.51B-0.7%3.53B+2.4%3.45B+3.6%3.33B+2.6%3.25B+4.9%
Property, plant & equipment912M-9.0%1.00B-6.7%1.07B-3.9%1.12B-6.0%1.19B-7.7%
Operating lease right-of-use36.2M+7.8%33.6M-21.4%42.7M+26.2%33.8M-21.2%42.9M-9.8%
Deferred tax assets77.4M+12.0%69.1M+8.0%64.0M+51.3%42.3M+46.1%28.9M+23.4%
Other non-current assets93.1M+60.3%58.1M-2.8%59.8M-4.9%62.8M-8.8%68.9M-1.9%
902M+8.0%835M+0.9%828M-3.6%859M-11.1%966M+25.0%
Accounts payable571M-5.1%601M+6.9%562M-4.6%590M-6.3%629M+11.4%
Accrued liabilities772M-2.8%795M+1.6%783M-5.5%828M-6.5%886M+16.9%
Deferred revenue50.1M+6.1%47.2M-22.7%61.0M-3.0%62.9M+2.4%61.4M+18.9%
Current lease liability9.55M-16.3%11.4M+1.4%11.3M+16.0%9.70M-17.2%11.7M-15.2%
Finance lease liability (current)
————0.00-100.0%
Non-current lease liability26.3M+17.9%22.3M-29.6%31.7M+31.3%24.2M-22.0%31.0M-7.3%
Operating lease liability (total)35.9M+6.3%33.8M-21.5%43.0M+26.9%33.9M-20.7%42.7M-9.5%
Finance lease liability (total)0.000.000.000.000.00-100.0%
Finance lease liability
————0.00
Other non-current liabilities372M+4.5%356M-4.0%371M+13.8%326M+18.2%276M-1.2%
1.78B-1.0%1.80B+5.8%1.70B+6.2%1.60B+10.2%1.45B+0.7%
Common stock1.24M+0.0%1.24M+0.1%1.24M+0.0%1.24M+0.0%1.24M+0.0%
Additional paid-in capital975M+0.4%972M+0.4%967M+0.5%963M+0.6%957M+0.3%
Retained earnings6.31B+1.4%6.23B+3.0%6.05B+7.1%5.65B+12.3%5.03B+12.4%
Treasury stock5.46B+2.0%5.35B+2.3%5.23B+5.7%4.95B+9.7%4.51B+14.2%
Accumulated other comprehensive income-46.7M+6.4%-49.9M+42.8%-87.2M-32.7%-65.7M-188.3%-22.8M+34.7%
Total liabilities & equity3.51B-0.7%3.53B+2.4%3.45B+3.6%3.33B+2.6%3.25B+4.9%
Cash Flowas ofJan 31 ’26as ofFeb 1 ’25as ofFeb 3 ’24as ofJan 28 ’23as ofJan 29 ’22
717M+0.4%714M-19.2%884M-6.8%948M-25.9%1.28B+406.0%
Depreciation & amortization179M+0.8%178M-1.0%180M-4.7%188M-5.5%199M-6.6%
Deferred income taxes-7.31M+18.7%-8.99M+49.3%-17.7M-15.9%-15.3M-105.4%-7.45M+68.9%
Change in receivables-16.0M-229.6%-4.85M-234.8%3.60M-79.1%17.2M+456.9%3.08M+132.6%
22.5M+108.4%-270M-133.3%-116M+51.0%-236M-238.0%-69.8M-44.2%
Capital expenditure93.4M-10.7%105M-21.4%133M+10.7%120M+15.1%104M+72.6%
Free cash flow624M+2.3%610M-18.8%751M-9.4%828M-29.5%1.18B+510.8%
Acquisitions0.000.000.000.000.00
-596M-11.4%-535M+13.7%-620M+19.4%-769M+9.9%-854M-603.9%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.00-100.0%44.8M0.00
Common stock issued0.000.000.000.000.00
Common stock repurchased108M-11.0%121M-57.0%281M-37.9%453M-16.9%545M+429.6%
Dividends paid485M+17.2%414M+22.2%339M+24.8%271M-11.1%305M+2084.0%
Interest paid40.9M+9.1%37.5M-16.7%45.0M+0.7%44.7M-0.2%44.8M-7.4%
Income taxes paid134M-10.8%151M-18.1%184M-21.8%235M+151.0%93.6M+17.1%
Valuation Ratiosas ofJan 31 ’26as ofFeb 1 ’25as ofFeb 3 ’24as ofJan 28 ’23as ofJan 29 ’22
Market cap9.49B+27.4%7.44B+17.2%6.35B-2.3%6.50B+33.3%4.88B+152.6%
P/E16.3×+38.1%11.8×+44.7%8.2×+16.1%7.0×-12.2%8.0×
P/S1.5×+28.6%1.1×+20.1%0.9×-0.1%0.9×+17.4%0.8×+98.5%
P/B4.6×+22.3%3.8×+8.3%3.5×-13.3%4.0×+29.5%3.1×+122.9%
P/FCF12.1×+9.0%11.1×+24.0%9.0×+36.9%6.6×+28.5%5.1×-48.6%
Earnings yield6.1%-27.6%8.5%-30.9%12.2%-13.8%14.2%+13.9%12.5%
FCF yield8.2%-8.3%9.0%-19.3%11.1%-27.0%15.2%-22.2%19.6%+94.5%
Dividend yield5.1%-7.8%5.6%+4.1%5.3%+28.3%4.2%-33.5%6.3%+815.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: DDS’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all DDS filings on SEC EDGAR → Not investment advice.